Title
A Distinct EEG Marker of Celiac Disease-Related Cortical Myoclonus
Date Issued
01 April 2021
Access level
metadata only access
Resource Type
journal article
Author(s)
Swinkin E.
Algarni M.
Garcia Dominguez L.
Baarbé J.K.
Saravanamuttu J.
Chen R.
Slow E.
Lang A.E.
Wennberg R.A.
University of Toronto
Publisher(s)
John Wiley and Sons Inc
Wiley-Blackwell
Abstract
Background: Celiac disease is associated with motor cortex hyperexcitability and neurological manifestations including cortical myoclonus. Electroencephalography abnormalities have been described, but no distinct pattern has been reported. Methods: We describe the neurophysiological characteristics of 3 patients with celiac-associated cortical myoclonus using electroencephalography, magnetoencephalography, and transcranial magnetic stimulation. Results: Electroencephalography in all cases demonstrated lateralized low-amplitude, electropositive beta-frequency polyspike activity over the central head region, corresponding to motor cortex contralateral to the myoclonic limb. Jerk-locked back-averaging demonstrated a preceding cortical potential; magnetoencephalography source localization revealed a cortical generator in the posterior wall of the precentral gyrus for the back-averaged potential and oscillatory abnormality. In 1 patient, cerebellar inhibition of the motor cortex was physiologically normal. Conclusions: Central head oscillatory, low-amplitude, electropositive electroencephalography polyspike activity may be a distinct marker of celiac-related cortical myoclonus and is consistent with celiac-related motor cortex hyperexcitability, which may not necessarily result from cerebellar disinhibition. © 2020 International Parkinson and Movement Disorder Society.
Start page
999
End page
1005
Volume
36
Issue
4
Language
English
OCDE Knowledge area
Neurología clínica
Scopus EID
2-s2.0-85096864357
PubMed ID
Source
Movement Disorders
ISSN of the container
0885-3185
Sponsor(s)
E.S.: Parkinson Canada clinical movement disorders fellowship funding. R.C.: Honoraria from Allergan, Merz, and Ipsen; Funding sources — Canadian Institutes of Health Research, National Institutes of Health, Natural Science and Engineering Research Council of Canada, Canada Foundation for Innovation, Dystonia Medical Research Foundation, National Organization for Rare Disease.
Sources of information: Directorio de Producción Científica Scopus